Dr Reddy's launches generic arthritis drug in US market
"The launch of product is an important addition to our pain/analgesics portfolio of over-the-counter (OTC) products, and represents our continued commitment to the private label OTC space," Dr Reddy's Laboratories North America Generics CEO Marc K...
"The launch of product is an important addition to our pain/analgesics portfolio of over-the-counter (OTC) products, and represents our continued commitment to the private label OTC space," Dr Reddy's Laboratories North America Generics CEO Marc Kikuchi said in a statement.
The company has partnered with Encube Ethicals to bring this product to market for the benefit of consumers, he added.
Diclofenac Sodium topical gel is used for temporary relief of arthritis pain in hand, wrist, elbow, foot, ankle and knee.
According to IRI data, the Voltaren brand had total retail sales of around USD 44 million since launch in May 2020.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.